Primary Care Clinician Decision-Making Around Surveillance Colonoscopies in Older Adults with Prior Adenomas.
Primary Care Clinician Decision-Making Around Surveillance Colonoscopies in Older Adults with Prior Adenomas.
复制标题
DOI：
10.3122/jabfm.2020.05.200075
复制
发表时间：
2020-09
期刊：
影响因子：
--
通讯作者：
Pollack CE
中科院分区：
文献类型：
--
作者：
Schoenborn NL;Boyd CM;Massare J;Park R;Choi Y;Pollack CE
While guidelines recommend against routine colorectal cancer screening in adults >75 years and/or those with limited life expectancies, there is no clear guidance on when surveillance colonoscopies following prior adenoma detection should stop. How primary care clinicians weigh the potential risks and benefits of surveillance colonoscopies in older adults with prior adenomas is unknown. We conducted semi-structured in-person interviews with 30 primary care clinicians from 21 clinics in Maryland. We asked how clinicians decided whether to continue or stop surveillance colonoscopies in older patients with prior adenomas. Interview transcripts were independently coded by two investigators using qualitative content analysis. Participants described a range of decision-making approaches. Some deferred to specialists because they did not feel confident making decisions about stopping surveillance in light of the higher cancer risk involved. Some took a more active role and discussed the decision with patients and/or specialists. Other clinicians felt comfortable stopping surveillance colonoscopies and made these decisions based on patient age, comorbidities, or life expectancy. We found a range of decision-making approaches among primary care clinicians on whether to continue surveillance colonoscopies in older adults with prior adenomas. Separate bodies of evidence currently exist on how prior adenoma characteristics influence colorectal cancer risk and on how older age and declining health influence the benefit/harm balance of screening. Information is lacking on the benefits and harms of surveillance in older adults with prior adenomas. Developing the evidence to address this knowledge gap is critically needed to inform clinical decision-making.
登录
查看更多内容
影响因子：
7.7
作者：
Rex, Douglas K.;Boland, C. Richard;Robertson, Douglas J.
通讯作者：
Robertson, Douglas J.
影响因子：
5.7
作者：
Kruse, Gina R.;Khan, Sami M.;Sequist, Thomas D.
通讯作者：
Sequist, Thomas D.
影响因子：
39.2
作者：
Qaseem, Amir;Crandall, Carolyn J.;Vijan, Sandeep
通讯作者：
Vijan, Sandeep
影响因子：
29.4
作者：
Gupta S;Lieberman D;Anderson JC;Burke CA;Dominitz JA;Kaltenbach T;Robertson DJ;Shaukat A;Syngal S;Rex DK
通讯作者：
Rex DK